28 related news articles for Endocrine hypertension

The establishment of the Primary Aldosteronism Centre of Research Excellence (PACE), brings together world-class researchers to improve the diagnosis of primary aldosteronism (PA)…  Read more

Two researchers at the forefront of Hudson Institute’s work on Primary Aldosteronism (PA) have been recognised for their efforts to increase understanding and treatment of the condition.…  Read more

Hudson Institute is a key player in an exciting new primary aldosteronism (PA) project investigating the causes of primary aldosteronism, a common and potentially preventable cause of cardiovascular disease.…  Read more

Hudson Institute researchers have had some great success in the recent NHMRC Grant rounds.…  Read more

A hidden cause of disease for more than half a million Australians – and the researchers pioneering its detection and treatment – have been recognised in a big way, with Hudson Institute to be home to the new NHMRC Primary Aldosteronism Centre of Excellence (PACE).…  Read more

Alarming levels of a major hypertension risk have been found among Indigenous people in Australia’s Top End, in a first-of-its-kind study.…  Read more

Director’s message: For children with cancer, change starts here. Childhood cancer is rare but devastating and new treatment options are desperately needed. In the last four decades the US Food and Drug Authority (FDA) has approved 500 drugs for adult cancers but just 12 to treat childhood cancers.…  Read more

It was a simple suggestion that led Associate Professor Jun Yang to begin studying primary aldosteronism (PA), but when she discovered both her parents had the condition, she knew she was onto something.…  Read more

Two leading Hudson Institute researchers are taking their discoveries closer to the clinic and bringing better health to the lives of preterm babies and Australians with hypertension, thanks to significant new funding.…  Read more

They’ve already identified a major undiagnosed cause of hypertension (high blood pressure), now the same team of researchers is helping doctors to better assess hypertension risk.…  Read more

Hudson Institute research has been recognised for its impact on Victoria’s healthcare, with two projects named as finalists in the 2022 Victorian Public Healthcare Awards.…  Read more

After watching her father struggle with hypertension (high blood pressure) for decades, endocrinologist Dr Jun Yang found he had a hormonal condition called primary aldosteronism (PA).…  Read more

After identifying Primary Aldosteronism (PA) as a significant cause of high blood pressure, Dr Jun Yang is now leading a multi-state push to have hospitals equipped to treat the condition.…  Read more

A simple blood test for primary aldosteronism could save more than half a million Australians from unnecessary illness, medication and expense, a new study has found…  Read more

Hudson Institute scientists have found that a hormone that can cause high blood pressure has been found to behave differently in young men and women, possibly paving the way for more targeted diagnosis and treatment.…  Read more

After watching her father struggle to battle hypertension — or high blood pressure — for decades, Dr Jun Yang ran some tests and was able to find one targeted treatment that successfully lowered his blood pressure to a healthy level for the first time.…  Read more

A clinical service and primary care outreach program focused on hormonal causes of high blood pressure — the first of its kind in Victoria — has led to earlier screening and diagnosis of primary aldosteronism.…  Read more

Hudson Institute is delighted to announce the success of our researchers in the latest NHMRC Investigator Grant round. Internationally-renowned childhood sleep expert Professor Rosemary Horne has been awarded more than $2 million to pursue studies investigating the implications of impaired sleep on the developing brain, while Dr Jun Yang has been awarded more than half…  Read more

Five Hudson Institute researchers have been awarded one-year Medicine/Science grants totalling nearly $300,000 by The CASS Foundation, to advance their research projects into mitochondrially-driven cancers, ovarian cancer, Parkinson’s disease, primary aldosteronism and endometriosis in 2020.…  Read more

Hudson Institute has had outstanding success in the NHMRC Ideas Grant round.

Our researchers have been awarded nine NHMRC Ideas Grants, totalling almost $8.5 million and a success rate of 19.1 per cent.…  Read more

Researchers have made an evolution related breakthrough in discovering the critical change in hormonal salt regulation that allowed life to evolve out of the seas and onto land.…  Read more

Two Hudson Institute researchers, Dr Jun Yang and Dr Maree Bilandzic have been successful in the 2019 IMPACT Philanthropy program, from Perpetual, which are awarded to organisations based on their strategy, outcomes, capability and leaderships.…  Read more

High blood pressure, or hypertension, continues to claim the lives of millions worldwide each year, despite the fact it only takes minutes to detect through screening.…  Read more

While most of us know a good night’s sleep is important for our health, a new study has pinpointed why it also could be crucial for maintaining a healthy heart. A study by Dr Morag Young, and students Elizabeth Fletcher and Monica Kanki, shows how changes in our heart’s circadian clock, as might occur with…  Read more

Dr Jun Yang has been awarded a prestigious $100,000 research grant from the Rebecca L Cooper Medical Research Foundation to find out more about how aldosterone might cause cardiovascular disease. Aldosterone is an important hormone in our body, but if produced in excess it can cause high blood pressure, stroke and heart attack. While it’s…  Read more

Australia’s largest study of a common yet underdiagnosed cause of high blood pressure is starting at Hudson Institute, with the aim of preventing heart attack and stroke. Primary aldosteronism (PA) is a potentially curable cause of high blood pressure (hypertension) caused by the over-production of the hormone aldosterone from the adrenal glands. If left undiagnosed,…  Read more

A multidisciplinary team of researchers and clinicians from Hudson Institute and Monash Health has refined a complex procedure, adrenal vein sampling (AVS), used to identify a surgically curable form of hypertension caused by primary aldosteronism (PA).…  Read more

Melbourne’s first dedicated Endocrine Hypertension Clinic is opening its doors at Monash Health on July 21 to improve treatment of a common yet underdiagnosed cause of high blood pressure. Hudson Institute of Medical Research’s Centre for Endocrinology and Metabolism (CEM) clinician-researchers, Professor Peter Fuller, Dr Jun Yang and Dr Jimmy Shen, are behind the new…  Read more